1. Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis. (13th October 2019) Authors: Weitz, Jeffrey I.; Segers, Annelise; Raskob, Gary; Roberts, Robin S.; Francis, Charles; Lassen, Michael Rud; Fuji, Takeshi; Swaim, Renée M.; Lee, Michael; Peters, Gary; DiBattiste, Peter M.; Tesfaye, Fisseha; Strony, John Journal: Journal of thrombosis and haemostasis Issue: Volume 17:Number 12(2019) Page Start: 2081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗